Vitiligo is a chronic autoimmune skin condition in which the immune system targets melanocytes—the cells responsible for producing skin pigment—resulting in the development of white patches on various parts of the body. These areas commonly include the face, hands, arms, and other sun-exposed regions, though vitiligo can affect any part of the skin.
The condition varies widely between individuals, with some experiencing slow progression while others may see more rapid or widespread depigmentation. Although vitiligo is not physically painful, its visible nature can have a significant emotional and psychological impact.
Current treatment options include topical therapies, phototherapy, and systemic treatments aimed at stabilizing the condition and promoting repigmentation. However, results can be inconsistent, and not all patients achieve satisfactory outcomes.
Clinical trials play a vital role in advancing new treatment options for vitiligo. At Rejuvenation Dermatology, our studies focus on evaluating innovative therapies that target immune pathways and stimulate melanocyte regeneration.
Participants receive access to investigational treatments within a controlled, medically supervised environment. Each study follows strict ethical and regulatory standards, ensuring patient safety while contributing to the development of more effective and targeted therapies.
Our goal is to restore pigmentation, prevent further depigmentation, and improve quality of life for individuals living with vitiligo.
STUDY INFO:
A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
If you are interested in joining this study, please click here.
STUDY INFO:
A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
If you are interested in joining this study, please click here.
EVIDENCE DRIVES BETTER VITILIGO CARE
We believe vitiligo treatment should be guided by strong clinical evidence and long-term outcomes. Our clinical trials are designed to evaluate advanced therapies that target immune-driven depigmentation and support repigmentation.
RESEARCH INTEGRATED INTO REAL CLINICAL PRACTICE
All studies are conducted within active dermatology clinics, ensuring patients receive care in a familiar and professional setting. Our dermatologists understand both the clinical and emotional impact of vitiligo and provide comprehensive care.
ETHICS ARE NON-NEGOTIABLE
Every vitiligo trial undergoes independent ethics board review before enrollment begins. Participants are fully informed, carefully screened, and continuously monitored, with safety protocols that meet and exceed regulatory standards.
STANDARDIZED, NATIONAL EXECUTION
Our multi-site research network operates under centralized oversight and standardized protocols, ensuring consistent execution, high-quality data collection, and reliable outcomes across all participating locations.
Clinical research at Rejuvenation Dermatology is driven by a commitment to advance patient care through evidence-based medicine. Through participating in regulated clinical trials, the organization helps to shape development of safer, more effective dermatologic treatments while ensuring patients receive care that meets the highest ethical and scientific standards.
Participation in clinical research enables Rejuvenation physicians to remain at the forefront of dermatologic innovation and provides patients with access to therapies that may not yet be commercially available.
DERMATOLOGY-LED RESEARCH
Our vitiligo trials are led by experienced dermatologists with expertise in autoimmune and pigmentary skin disorders. Physician oversight ensures every participant receives clinically sound, research-driven care.
FOCUS ON REPIGMENTATION AND STABILITY
Vitiligo requires both stabilization of disease progression and restoration of pigment. Our studies are designed to address both aspects for more comprehensive treatment outcomes.
SAFETY FIRST, ALWAYS
Patient safety is at the core of every study. Strict eligibility criteria, ongoing monitoring, and adherence to Good Clinical Practice guidelines ensure a safe and controlled research environment.
CONSISTENT EXECUTION, TRUSTED RESULTS
Sponsors rely on our ability to recruit efficiently and deliver high-quality, audit-ready data. This structured approach ensures a seamless and reliable experience for participants.
ADVANCING FUTURE VITILIGO THERAPIES
Participation in clinical trials contributes to the development of new therapies that may significantly improve long-term outcomes for individuals living with vitiligo.
Participants may access new therapies while receiving expert dermatological care.
Vitiligo is an autoimmune skin condition that causes loss of pigment, resulting in white patches on the skin.
Eligibility depends on the specific study but generally includes individuals with active or stable vitiligo.
Yes, all trials follow strict safety and ethical standards.
VITILIGO CLINICAL TRIALS | CLINICAL TRIALS CANADA | REJUVENATION DERMATOLOGY
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
